Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Brian Tomlinson, Paul Chan, Yuzhen Zhang, Zhongmin Liu & Christopher Wai Kei Lam. (2020) Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 371-385.
Read now
Read now
Chaorui Guo, Siqi Xue, Xiufen Zheng, Yang Lu, Di Zhao, Xijing Chen & Ning Li. (2018) The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats. Xenobiotica 48:4, pages 400-406.
Read now
Read now
Aleksi Tornio, Pertti J. Neuvonen, Mikko Niemi & Janne T. Backman. (2017) Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 83-95.
Read now
Read now
Ru-Dee Ting & Anthony Keech. (2013) Fenofibrate and renal disease: clinical effects in diabetes. Clinical Lipidology 8:6, pages 669-680.
Read now
Read now
Anna Koenen, Heyo K Kroemer, Markus Grube & Henriette E Meyer zu Schwabedissen. (2011) Current understanding of hepatic and intestinal OATP-mediated drug–drug interactions. Expert Review of Clinical Pharmacology 4:6, pages 729-742.
Read now
Read now
Adam J Foley-Comer, Anne-Marie Young, Fiona Russell-Yarde & Paul Jordan. (2011) Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin. Expert Opinion on Investigational Drugs 20:1, pages 3-12.
Read now
Read now
Alice C Rodrigues. (2010) Efflux and uptake transporters as determinants of statin response. Expert Opinion on Drug Metabolism & Toxicology 6:5, pages 621-632.
Read now
Read now
P. Annaert, Z.W. Ye, B. Stieger & P. Augustijns. (2010) Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica 40:3, pages 163-176.
Read now
Read now
P. Sharma, V. E. Holmes, R. Elsby, C. Lambert & D. Surry. (2010) Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions. Xenobiotica 40:1, pages 24-37.
Read now
Read now
Adie Viljoen & Anthony S Wierzbicki. (2009) Towards companion diagnostics for the management of statin therapy. Expert Opinion on Medical Diagnostics 3:6, pages 659-671.
Read now
Read now
R. Nakagomi-Hagihara, D. Nakai, T. Tokui, T. Abe & T. Ikeda. (2007) Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica 37:5, pages 474-486.
Read now
Read now
Articles from other publishers (67)
Jose J.G. Marin, Candela Cives-Losada, Rocio I.R. Macias, Marta R. Romero, Rebeca P. Marijuan, Nazaret Hortelano-Hernandez, Kevin Delgado-Calvo, Carmen Villar, Jesus M. Gonzalez-Santiago, Maria J. Monte & Maitane Asensio. (2024) Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition. Biochemical Pharmacology, pages 116166.
Crossref
Crossref
Nicola Ferri, Elisa Colombo, Marco Tenconi, Ludovico Baldessin & Alberto Corsini. (2022) Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Pharmaceutics 14:6, pages 1120.
Crossref
Crossref
Min Wang, Yingying Sun, Bingying Hu, Zhisheng He, Shanshan Chen, Dake Qi, Hai An & Yang Wei. (2022) Organic Cation Transporters are Involved in Fluoxetine Transport Across
the Blood-Brain Barrier In Vivo and In Vitro.. Current Drug Delivery 19:4, pages 508-517.
Crossref
Crossref
Nada Božina, Lana Ganoci, Livija Simičević, Katarina Gvozdanović, Iva Klarica Domjanović, Margareta Fistrek Prlić, Tena Križ, Ana Borić Bilušić, Mario Laganović & Tamara Božina. (2021) Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review. Archives of Industrial Hygiene and Toxicology 72:2, pages 114-128.
Crossref
Crossref
Péter Tátrai, Franciska Erdő, Gabriella Dörnyei & Péter Krajcsi. (2021) Modulation of Urate Transport by Drugs. Pharmaceutics 13:6, pages 899.
Crossref
Crossref
Magda Dubińska-Magiera, Marta Migocka-Patrzałek, Damian Lewandowski, Małgorzata Daczewska & Krzysztof Jagla. (2021) Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies. International Journal of Molecular Sciences 22:11, pages 5654.
Crossref
Crossref
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Konstantinos E. Iliodromitis, Theodore G. Papaioannou, Giulio G. Stefanini, Michael Cleman, Gerasimos Siasos, Bernhard Reimers, Alexandra Lansky, Jean-Claude Tardif, Spyridon G. Deftereos & George Giannopoulos. (2021) Repurposing colchicine’s journey in view of drug-to-drug interactions. A review. Toxicology Reports 8, pages 1389-1393.
Crossref
Crossref
Alberto Corsini & Nicola Ferri. 2021. Direct Oral Anticoagulants. Direct Oral Anticoagulants
41
69
.
Sabrina T. Wiebe, Thomas Giessmann, Kathrin Hohl, Sven Schmidt-Gerets, Edith Hauel, Alen Jambrecina, Kerstin Bader, Naoki Ishiguro, Mitchell E. Taub, Ashish Sharma, Thomas Ebner, Gerd Mikus, Martin F. Fromm, Fabian Müller & Peter Stopfer. (2020) Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. Clinical Pharmacokinetics 59:12, pages 1627-1639.
Crossref
Crossref
Hae Won Lee, Woo Youl Kang, Wookjae Jung, Mi-Ri Gwon, Kyunghee Cho, Dong Heon Yang, Young-Ran Yoon & Sook Jin Seong. (2020) Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers. Pharmaceutics 12:9, pages 869.
Crossref
Crossref
Alberto Corsini, Nicola Ferri, Marco Proietti & Giuseppe Boriani. (2020) Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice. Drugs 80:11, pages 1065-1083.
Crossref
Crossref
Jelena Dragojević, Petra Marić, Jovica Lončar, Marta Popović, Ivan Mihaljević & Tvrtko Smital. (2020) Environmental contaminants modulate transport activity of zebrafish organic anion transporters Oat1 and Oat3. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 231, pages 108742.
Crossref
Crossref
Petra M. Hermann, Alexander C. Perry, Izen Hamad & Willem C. Wildering. (2020) Physiological and pharmacological characterization of a molluscan neuronal efflux transporter; evidence for age-related transporter impairment. Journal of Experimental Biology.
Crossref
Crossref
Reo Kawata & Tsuyoshi Yokoi. (2019) Analysis of a Skeletal Muscle Injury and Drug Interactions in Lovastatin- and Fenofibrate-Coadministered Dogs. International Journal of Toxicology 38:3, pages 192-201.
Crossref
Crossref
Martin Poruba, Zuzana Matuskova, Martina Hüttl, Hana Malinska, Olena Oliyarnyk, Irena Markova, Sona Gurska, Ludmila Kazdova & Rostislav Vecera. (2019) Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia. Frontiers in Pharmacology 10.
Crossref
Crossref
Marcin Luty, Katarzyna Piwowarczyk, Anna Łabędź-Masłowska, Tomasz Wróbel, Małgorzata Szczygieł, Jessica Catapano, Grażyna Drabik, Damian Ryszawy, Sylwia Kędracka-Krok, Zbigniew Madeja, Maciej Siedlar, Martyna Elas & Jarosław Czyż. (2019) Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel. Cancers 11:1, pages 77.
Crossref
Crossref
Romil Saxena. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach
445
464
.
Min Luo, Manyun Dai, Hante Lin, Minzhu Xie, Jiao Lin, Aiming Liu & Julin Yang. (2017) Species‐related exposure of phase II metabolite gemfibrozil 1‐O‐β‐glucuronide between human and mice: A net induction of mouse P450 activity was revealed. Biopharmaceutics & Drug Disposition 38:9, pages 535-542.
Crossref
Crossref
Anton Ivanyuk, Françoise Livio, Jérôme Biollaz & Thierry Buclin. (2017) Renal Drug Transporters and Drug Interactions. Clinical Pharmacokinetics 56:8, pages 825-892.
Crossref
Crossref
Matthew M. Weiss, Thomas A. Dineen, Isaac E. Marx, Steven Altmann, Alessandro Boezio, Howard Bregman, Margaret Chu-Moyer, Erin F. DiMauro, Elma Feric Bojic, Robert S. Foti, Hua Gao, Russell Graceffa, Hakan Gunaydin, Angel Guzman-Perez, Hongbing Huang, Liyue Huang, Michael Jarosh, Thomas Kornecook, Charles R. Kreiman, Joseph Ligutti, Daniel S. La, Min-Hwa Jasmine Lin, Dong Liu, Bryan D. Moyer, Hanh N. Nguyen, Emily A. Peterson, Paul E. Rose, Kristin Taborn, Beth D. Youngblood, Violeta Yu & Robert T. FremeauJr.Jr.. (2017)
Sulfonamides as Selective Na
V
1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
. Journal of Medicinal Chemistry 60:14, pages 5969-5989.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Mohammad Asif Emran Khan Emon, Alpha Tom Kodamullil, Reagon Karki, Erfan Younesi & Martin Hofmann-Apitius. (2017) Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases. Journal of Alzheimer's Disease 56:2, pages 677-686.
Crossref
Crossref
Jarno E. J. Wolters, Marcel H. M. van Herwijnen, Daniel H. J. Theunissen, Danyel G. J. Jennen, Wim F. P. M. Van den Hof, Theo M. C. M. de Kok, Frank G. Schaap, Simone G. J. van Breda & Jos C. S. Kleinjans. (2016) Integrative “-Omics” Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis. Chemical Research in Toxicology 29:12, pages 2164-2174.
Crossref
Crossref
R. Subramanian, X. Zhu, S. J. Kerr, J. D. Esmay, S. W. Louie, K. Z. Edson, S. Walter, M. Fitzsimmons, M. Wagner, M. Soto, R. Pham, S. F. Wilson & G. L. Skiles. (2016) Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel D-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide). Drug Metabolism and Disposition 44:8, pages 1319-1331.
Crossref
Crossref
R. Elsby, P. Martin, D. Surry, P. Sharma & K. Fenner. (2015) Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure. Drug Metabolism and Disposition 44:3, pages 398-408.
Crossref
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref
Crossref
Yuan Feng, Changyuan Wang, Qi Liu, Qiang Meng, Xiaokui Huo, Zhihao Liu, Pengyuan Sun, Xiaobo Yang, Huijun Sun, Jianhua Qin & Kexin Liu. (2016) Bezafibrate–mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats. European Journal of Pharmaceutical Sciences 81, pages 119-128.
Crossref
Crossref
Lori A. Gordon, Christine Y. Malati, Colleen Hadigan, Mary McLaughlin, Raul M. Alfaro, Mónica M. Calderón, Joseph A. Kovacs & Scott R. Penzak. (2016) Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:1, pages 49-56.
Crossref
Crossref
Saeed Alqahtani & Amal Kaddoumi. (2015) Development of a physiologically based pharmacokinetic/pharmacodynamic model to identify mechanisms contributing to entacapone low bioavailability. Biopharmaceutics & Drug Disposition 36:9, pages 587-602.
Crossref
Crossref
Robert D. Barrington, Paul W. Needs, Gary Williamson & Paul A. Kroon. (2015) MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux. Biochemical Pharmacology 95:3, pages 193-200.
Crossref
Crossref
Mina Khezrian, Behjat Sheikholeslami, Simin Dadashzadeh, Hoda Lavasani & Mohammadreza Rouini. (2015) Effects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver model. Cancer Chemotherapy and Pharmacology 75:5, pages 961-968.
Crossref
Crossref
Vineet Kumar, Bhagwat Prasad, Gabriela Patilea, Anshul Gupta, Laurent Salphati, Raymond Evers, Cornelis E. C. A. Hop & Jashvant D. Unadkat. (2015) Quantitative Transporter Proteomics by Liquid Chromatography with Tandem Mass Spectrometry: Addressing Methodologic Issues of Plasma Membrane Isolation and Expression-Activity Relationship. Drug Metabolism and Disposition 43:2, pages 284-288.
Crossref
Crossref
Jingjing Sheng, Xiaoting Tian, Guanglin Xu, Zhitao Wu, Chen Chen, Le Wang, Lili Pan, Chenggang Huang & Guoyu Pan. (2015) The Hepatobiliary Disposition of Timosaponin B2 Is Highly Dependent on Influx/Efflux Transporters but Not Metabolism. Drug Metabolism and Disposition 43:1, pages 63-72.
Crossref
Crossref
Marta Popovic, Roko Zaja, Karl Fent & Tvrtko Smital. (2014) Interaction of environmental contaminants with zebrafish organic anion transporting polypeptide, Oatp1d1 (Slco1d1). Toxicology and Applied Pharmacology 280:1, pages 149-158.
Crossref
Crossref
Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges & Kim L. R. Brouwer. (2014) Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat. Drug Metabolism and Disposition 42:9, pages 1567-1574.
Crossref
Crossref
H. Schelleman, X. Han, C. M. Brensinger, S. K. Quinney, W. B. Bilker, D. A. Flockhart, L. Li & Sean Hennessy. (2014)
Pharmacoepidemiologic and
in vitro
evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins
. British Journal of Clinical Pharmacology 78:3, pages 639-648.
Crossref
Crossref
Anneke Winsemius, Jean‐Claude Ansquer, Matthias Olbrich, Peter van Amsterdam, Patrick Aubonnet, Katrin Beckmann, Stefan Driessen, Hanneke van Assche, Gabi Piskol, Dirk Lehnick & Katsuhiro Mihara. (2014) Pharmacokinetic interaction between simvastatin and fenofibrate with staggered and simultaneous dosing: Does it matter?. The Journal of Clinical Pharmacology 54:9, pages 1038-1047.
Crossref
Crossref
Brian C. Ferslew, Kathleen Köck & Kim L. R. Brouwer. 2014. Drug Transporters. Drug Transporters
245
271
.
Rocco Ciracì, Giampaolo Tirone & Francesco Scaglione. (2014) The impact of drug–drug interactions on pulmonary arterial hypertension therapy. Pulmonary Pharmacology & Therapeutics 28:1, pages 1-8.
Crossref
Crossref
Natalia VanDuyn & Richard Nass. (2013)
The putative multidrug resistance protein
MRP
‐7 inhibits methylmercury‐associated animal toxicity and dopaminergic neurodegeneration in
Caenorhabditis elegans
. Journal of Neurochemistry 128:6, pages 962-974.
Crossref
Crossref
Marta Popovic, Roko Zaja, Karl Fent & Tvrtko Smital. (2013) Molecular Characterization of Zebrafish Oatp1d1 (Slco1d1), a Novel Organic Anion-transporting Polypeptide. Journal of Biological Chemistry 288:47, pages 33894-33911.
Crossref
Crossref
A M Filppula, A Tornio, M Niemi, P J Neuvonen & J T Backman. (2013) Gemfibrozil Impairs Imatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite. Clinical Pharmacology & Therapeutics 94:3, pages 383-393.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
353
454
.
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
261
294
.
Manthena V. S. Varma, Yurong Lai, Bo Feng, John Litchfield, Theunis C. Goosen & Arthur Bergman. (2012) Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions. Pharmaceutical Research 29:10, pages 2860-2873.
Crossref
Crossref
Yi-an Bi, Emi Kimoto, Samantha Sevidal, Hannah M. Jones, Hugh A. Barton, Sarah Kempshall, Kevin M. Whalen, Hui Zhang, Chengjie Ji, Katherine S. Fenner, Ayman F. El-Kattan & Yurong Lai. (2012) In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation. Drug Metabolism and Disposition 40:6, pages 1085-1092.
Crossref
Crossref
Jose J. G. Marin. (2012) Plasma Membrane Transporters in Modern Liver Pharmacology. Scientifica 2012, pages 1-15.
Crossref
Crossref
Yoshiyuki Sasaki, Tsutomu Shimada, Seiichi Iizuka, Wataru Suzuki, Hiroko Makihara, Ryutaro Teraoka, Koichi Tsuneyama, Ryoji Hokao & Masaki Aburada. (2011) Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. European Journal of Pharmacology 662:1-3, pages 1-8.
Crossref
Crossref
Steven W. Louie & Magang Shou. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
83
149
.
Lloyd R. Whitfield, Anthony R. Porcari, Christine Alvey, Robert Abel, William Bullen & Daniel Hartman. (2011) Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin. The Journal of Clinical Pharmacology 51:3, pages 378-388.
Crossref
Crossref
Yoshihisa Shitara. (2011) Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions. Drug Metabolism and Pharmacokinetics 26:3, pages 220-227.
Crossref
Crossref
Marwan Ghabril & Won Kyoo Cho. 2011. Practical Hepatic Pathology: A Diagnostic Approach. Practical Hepatic Pathology: A Diagnostic Approach
37
44
.
Ridhi Parasrampuria & Reza Mehvar. (2010) Dose-Dependent Inhibition of Transporter-Mediated Hepatic Uptake and Biliary Excretion of Methotrexate by Cyclosporine A in an Isolated Perfused Rat Liver Model. Journal of Pharmaceutical Sciences 99:12, pages 5060-5069.
Crossref
Crossref
Joseph E. Rower, Lane R. Bushman, Kyle P. Hammond, Rajendra S. Kadam & Christina L. Aquilante. (2010) Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study. Biomedical Chromatography 24:12, pages 1300-1308.
Crossref
Crossref
Curtis D. Klaassen & Lauren M. Aleksunes. (2010) Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation. Pharmacological Reviews 62:1, pages 1-96.
Crossref
Crossref
Ridhi Parasrampuria & Reza Mehvar. (2010) Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers. Journal of Pharmaceutical Sciences 99:1, pages 455-466.
Crossref
Crossref
Amit S. Kalgutkar, Kosea S. Frederick, Jonathan Chupka, Bo Feng, Sarah Kempshall, Rochelle J. Mireles, Katherine S. Fenner & Matthew D. Troutman. (2009) N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a “chemical knock-out equivalent” to assess the impact of efflux transporters on oral drug absorption in the rat. Journal of Pharmaceutical Sciences 98:12, pages 4914-4927.
Crossref
Crossref
Terry A. Jacobson. (2009) Myopathy with statin–fibrate combination therapy: clinical considerations. Nature Reviews Endocrinology 5:9, pages 507-518.
Crossref
Crossref
Domenic A. Sica. (2009) Fibrate therapy and renal function. Current Atherosclerosis Reports 11:5, pages 338-342.
Crossref
Crossref
Daniel Caminada, Roko Zaja, Tvrtko Smital & Karl Fent. (2008) Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1. Aquatic Toxicology 90:3, pages 214-222.
Crossref
Crossref
A Tornio, M Niemi, M Neuvonen, J Laitila, A Kalliokoski, PJ Neuvonen & JT Backman. (2008) The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo. Clinical Pharmacology & Therapeutics 84:3, pages 403-411.
Crossref
Crossref
Hartmut Glaeser, Martin F. Fromm & Jörg König. 2008. Antitargets. Antitargets
341
366
.
Johannes Noé, Renée Portmann, Marie-Elise Brun & Christoph Funk. (2007) Substrate-Dependent Drug-Drug Interactions between Gemfibrozil, Fluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metabolism and Disposition 35:8, pages 1308-1314.
Crossref
Crossref
Xiao-Yan Chu, Kelly Bleasby, Jocelyn Yabut, Xiaoxin Cai, Grace Hoyee Chan, Michael J. Hafey, Shiyao Xu, Arthur J. Bergman, Matthew P. Braun, Dennis C. Dean & Raymond Evers. (2007) Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics 321:2, pages 673-683.
Crossref
Crossref
Y Y Lau, Y Huang, L Frassetto & L Z Benet. (2006) Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers. Clinical Pharmacology & Therapeutics 81:2, pages 194-204.
Crossref
Crossref
Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen & Mikko Niemi. (2006) SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenetics and Genomics 16:12, pages 873-879.
Crossref
Crossref
Eliisa Mannermaa, Kati-Sisko Vellonen & Arto Urtti. (2006) Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics. Advanced Drug Delivery Reviews 58:11, pages 1136-1163.
Crossref
Crossref